Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS SARS-CoV2 (COVID-19)

NCT04416334 is registered in ClinicalTrials.gov with Instituto de Investigación Marqués de Valdecilla as lead sponsor.

NCT NCT04416334
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04416334 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS SARS-CoV2 (COVID-19)
Lead sponsor
Instituto de Investigación Marqués de Valdecilla
Phase
Phase 3
Overall status
Completed
Start date
August 19, 2020
Completion date
October 11, 2022
Enrollment
70 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

sars-cov-2 infection (covid-19)